I always thought platform was the best route but I think the move away from internal candidates says a lot ? too hard basket again ? - they couldn't really bring attractive data packs up despite extending the time frame a couple of times ? The long long elusive pk/pd remains the way it has for years elusive ? I think it's all a bit in the air chop changing lead focus (again) - have swapped between internal candidates and delivery how many times now ?
Interesting year ahead I just hope they sell something in 2018 and it doesn't end with them going back to yet again another new (or old) strategy.
Ann: Phylogica Strategic Update - Pivot to Platform, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |